Roles of protein kinase B/Akt in lung cancer
- PMID: 20515818
- DOI: 10.2741/e206
Roles of protein kinase B/Akt in lung cancer
Abstract
Lung cancer is the leading cause of cancer-related death worldwide and has frequently been associated with over-activated protein kinase B (PKB)/Akt. Akt is a serine/threonine protein kinase that plays an important role in cell growth, proliferation, and survival. Many lines of evidence point to the contribution of deregulated Akt in development or progression of lung cancer. In addition, recent studies have demonstrated that cancer cells defend themselves from therapeutic treatment through activation of pro-survival signals, including the Akt pathway. In this review, we described the way in which the Akt pathway is activated in development and progression of lung cancer, and the way in which deregulated Akt plays a significant role in lung tumorigenesis and resistance to chemo- or radiotherapy. In this review, we also discussed the potential of the Akt pathway as a target of lung cancer therapy.
Similar articles
-
Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells.Cancer Res. 2004 Dec 1;64(23):8723-30. doi: 10.1158/0008-5472.CAN-03-3091. Cancer Res. 2004. PMID: 15574783
-
Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.Cancer Res. 2001 May 15;61(10):3986-97. Cancer Res. 2001. PMID: 11358816
-
Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.Cancer Res. 2006 Jan 1;66(1):315-23. doi: 10.1158/0008-5472.CAN-05-2367. Cancer Res. 2006. PMID: 16397245
-
The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer.J Thorac Oncol. 2009 Jun;4(6):761-7. doi: 10.1097/JTO.0b013e3181a1084f. J Thorac Oncol. 2009. PMID: 19404218 Review.
-
Diverse mechanisms of AKT pathway activation in human malignancy.Curr Cancer Drug Targets. 2013 Mar;13(3):234-44. doi: 10.2174/1568009611313030002. Curr Cancer Drug Targets. 2013. PMID: 23297823 Free PMC article. Review.
Cited by
-
HSP90: A Novel Target Gene of miRNA-628-3p in A549 Cells.Biomed Res Int. 2018 May 20;2018:4149707. doi: 10.1155/2018/4149707. eCollection 2018. Biomed Res Int. 2018. PMID: 29888262 Free PMC article.
-
Aerosol delivery of beclin1 enhanced the anti-tumor effect of radiation in the lungs of K-rasLA1 mice.J Radiat Res. 2012 Jul;53(4):506-15. doi: 10.1093/jrr/rrs005. Epub 2012 Jun 6. J Radiat Res. 2012. PMID: 22843615 Free PMC article.
-
Quadruplex-forming oligonucleotide targeted to the VEGF promoter inhibits growth of non-small cell lung cancer cells.PLoS One. 2019 Jan 25;14(1):e0211046. doi: 10.1371/journal.pone.0211046. eCollection 2019. PLoS One. 2019. PMID: 30682194 Free PMC article.
-
Ellagic acid promotes A549 cell apoptosis via regulating the phosphoinositide 3-kinase/protein kinase B pathway.Exp Ther Med. 2018 Jul;16(1):347-352. doi: 10.3892/etm.2018.6193. Epub 2018 May 18. Exp Ther Med. 2018. PMID: 29896260 Free PMC article.
-
Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells.Oncotarget. 2017 Mar 21;8(12):19172-19191. doi: 10.18632/oncotarget.13432. Oncotarget. 2017. PMID: 27880728 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous